Feasible concomitant treatment with eltrombopag and oral anticoagulation in a patient with chronic immune thrombocytopenia and severe cardiac comorbidities

被引：1
作者：
Sanchez-Gonzalez, Blanca [1 ]
Ancochea, Agueda [1 ]
Garcia-Pallarols, Francesc [1 ]
Jimenez, Carmen [1 ]
Pedro, Carme [1 ]
Besses, Carles [1 ]
机构：
[1] Hosp Mar IMIM, Dept Hematol, Barcelona, Spain
来源：
PLATELETS | 2014年 / 25卷 / 04期
关键词：
Thrombopoietin receptor agonist; eltrombopag; romiplostim; immune thrombocytopenia; platelets; anticoagulation; CONTROLLED-TRIAL; DOUBLE-BLIND; PURPURA; ROMIPLOSTIM; EFFICACY;
D O I：
10.3109/09537104.2013.770137
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：309 / 310
页数：2
相关论文
共 8 条
  • [1] [Anonymous], 2006, Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0
  • [2] Baldini S, 2012, PLATELETS
  • [3] Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
    Bussel, James B.
    Provan, Drew
    Shamsi, Tahir
    Cheng, Gregory
    Psaila, Bethan
    Kovaleva, Lidia
    Salama, Abdulgabar
    Jenkins, Julian M.
    Roychowdhury, Debasish
    Mayer, Bhabita
    Stone, Nicole
    Arning, Michael
    [J]. LANCET, 2009, 373 (9664) : 641 - 648
  • [4] Immune thrombocytopenia and anticoagulation: the role of romiplostim in the early treatment
    Cantoni, Nathan
    Heizmann, Marc
    Bargetzi, Mario
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (05) : 639 - 641
  • [5] Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura:: a double-blind randomised controlled trial
    Kuter, David J.
    Bussel, James B.
    Lyons, Roger M.
    Pullarkat, Vinod
    Gernsheimer, Terry B.
    Senecal, Francis M.
    Aledort, Louis M.
    George, James N.
    Kessler, Craig M.
    Sanz, Miguel A.
    Liebman, Howard A.
    Slovick, Frank T.
    de Wolf, J. Th M.
    Bourgeois, Emmanuelle
    Guthrie, Troy H., Jr.
    Newland, Adrian
    Wasser, Jeffrey S.
    Hamburg, Solomon I.
    Grande, Carlos
    Lefrere, Francois
    Lichtin, Alan Eli
    Tarantino, Michael D.
    Terebelo, Howard R.
    Viallard, Jean-Francois
    Cuevas, Francis J.
    Go, Ronald S.
    Henry, David H.
    Redner, Robert L.
    Rice, Lawrence
    Schipperus, Martin R.
    Guo, D. Matthew
    Nichol, Janet L.
    [J]. LANCET, 2008, 371 (9610) : 395 - 403
  • [6] International consensus report on the investigation and management of primary immune thrombocytopenia
    Provan, Drew
    Stasi, Roberto
    Newland, Adrian C.
    Blanchette, Victor S.
    Bolton-Maggs, Paula
    Bussel, James B.
    Chong, Beng H.
    Cines, Douglas B.
    Gernsheimer, Terry B.
    Godeau, Bertrand
    Grainger, John
    Greer, Ian
    Hunt, Beverley J.
    Imbach, Paul A.
    Lyons, Gordon
    McMillan, Robert
    Rodeghiero, Francesco
    Sanz, Miguel A.
    Tarantino, Michael
    Watson, Shirley
    Young, Joan
    Kuter, David J.
    [J]. BLOOD, 2010, 115 (02) : 168 - 186
  • [7] Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
    Rodeghiero, Francesco
    Stasi, Roberto
    Gernsheimer, Terry
    Michel, Marc
    Provan, Drew
    Arnold, Donald M.
    Bussel, James B.
    Cines, Douglas B.
    Chong, Beng H.
    Cooper, Nichola
    Godeau, Bertrand
    Lechner, Klaus
    Mazzucconi, Maria Gabriella
    McMillan, Robert
    Sanz, Miguel A.
    Imbach, Paul
    Blanchette, Victor
    Kuehne, Thomas
    Ruggeri, Marco
    George, James N.
    [J]. BLOOD, 2009, 113 (11) : 2386 - 2393
  • [8] Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
    Saleh, Mansoor N.
    Bussel, James B.
    Cheng, Gregory
    Meyer, Oliver
    Bailey, Christine K.
    Arning, Michael
    Brainsky, Andres
    [J]. BLOOD, 2013, 121 (03) : 537 - 545
1